Form 8-K - Current report:
SEC Accession No. 0001104659-20-115280
Filing Date
2020-10-15
Accepted
2020-10-15 15:55:35
Documents
3
Period of Report
2020-10-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2033295d1_8k.htm 8-K 20865
2 EXHIBIT 99.1 tm2033295d1_ex99-1.htm EX-99.1 41496
3 GRAPHIC image_001.jpg GRAPHIC 3584
  Complete submission text file 0001104659-20-115280.txt   68798
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 201241509
SIC: 2836 Biological Products, (No Diagnostic Substances)